Kshitij Verma

Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Combination Therapy

Top Venues

Molecular cancer therapeutics

Journal of the American Chemical Society

Molecules (Basel, Switzerland)

Genentech Inc

Texas Tech University Health Sciences Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Inc Feb 19 2018

United States

Postdoctoral Research Associate :: Discovery Chemistry

Education History

Texas Tech University Health Sciences Center May 29 2013 - Nov 03 2017

United States

PHD :: Pharmaceutical Sciences

Publications

Willem den Besten, Kshitij Verma, Sayumi Yamazoe, Nicole Blaquiere, Wilson Phung, Anita Izrael-Tomasevic, Melinda M Mulvihill, Elizabeth Helgason, Sumit Prakash, Tatiana Goncharov, Domagoj Vucic, Erin C Dueber, Wayne J Fairbrother, Ingrid Wertz, Kebing Yu, Steven T Staben
Primary Amine Tethered Small Molecules Promote the Degradation of X-Linked Inhibitor of Apoptosis Protein. Journal of the American Chemical Society 143 (28) (2021)
Nehal Gupta, Kshitij Verma, Sarath Nalla, Alok Kulshreshtha, Rajiv Lall, Sahdeo Prasad
Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin. Molecules (Basel, Switzerland) 25 (22) (2020)
Kshitij Verma, Nehal Gupta, Tianzhu Zang, Phumvadee Wangtrakluldee, Sanjay K Srivastava, Trevor M Penning, Paul C Trippier
AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells. Molecular cancer therapeutics 17 (9) (2018)